- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01919073
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot study will employ a randomized controlled clinical trial design comparing symptoms of children who complete the Brief Behavioral Intervention to a wait-list control. Children in the wait-list control will be waitlisted for four months prior to initiation of treatment, which is a typical wait for clinical care. Treatment will then be offered to the children on the wait-list.
All parts of the intervention and all measures of behavior and family functioning are part of standard clinical care. The parts of this protocol that are not standard clinical care are the following: 1. Randomization process with half of the patients on a waitlist for four months. Randomization will be block randomization stratified by gender. 2. Booster sessions for problem solving at three months and six months after last treatment session. In standard clinical care this occurs only if the patient calls and requests. 3. Collection of behavior and family functioning measures at three months and six months after the active treatment component.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Texas Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 2-5 years
- Subject diagnosed with a Disruptive Behavior Disorder
- Subject who has an English-speaking parent willing to take part in intervention.
- Subject must meet criteria for a Diagnostic and Statistical Manual (DSM-IV) Disruptive Behavior Disorder (ADHD and/or ODD) based upon history, clinical interview, and clinically significant cut-off scores on parent rating forms. Parent and teacher of each child will also be involved.
Exclusion Criteria:
- Parents who are not fluent in English
- Subjects with a diagnosed anxiety disorder, pervasive developmental disorder, intellectual disability, adjustment disorder, mood disorder or language disorder will also be excluded and referred for more appropriate services.
- Children with less severe behavior problems will not be included in the study but will be referred for more appropriate services.
- Patients taking medication to treat behavior and patients who have previously received treatment will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Immediate Treatment Group
The immediate treatment group will fill out the questions at the initial appointment and again after five treatment appointments.
They will fill the questions out again at the first follow-up treatment appointment (approximately 4-5 months from the initial appointment), and then at the next (and last) follow-up appointment (approximately 7-8 months).
The participants teacher will also be asked to fill out sets of questions.
|
•The immediate treatment group will fill out the questions at the initial appointment and again after five treatment appointments.
They will fill the questions out again at the first follow-up treatment appointment (approximately 4-5 months from the initial appointment), and then at the next (and last) follow-up appointment (approximately 7-8 months).
The participants teacher will also be asked to fill out sets of questions.
|
ACTIVE_COMPARATOR: Delayed Treatment Group
The wait list group will fill out the sets of questions again in 1-2 months.
The question sets will then be completed again before beginning treatment four months from the initial completion and then again after five treatment appointments.
The question sets will then be completed again at the first follow-up treatment appointment (approximately 8-9 months from the initial appointment) and at the next (and last) follow-up appointment (in about 11-12 months from the initial appointment).
|
•The wait list group will fill out the sets of questions again in 1-2 months.
The question sets will then be completed again before beginning treatment four months from the initial completion and then again after five treatment appointments.
The question sets will then be completed again at the first follow-up treatment appointment (approximately 8-9 months from the initial appointment) and at the next (and last) follow-up appointment (about 11-12 months from the initial appointment).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parent Behavioral Assessment System for Children- 2nd Edition (BASC2) Externalizing Score
Time Frame: 3 months
|
The primary outcome measure is the parent BASC2 Externalizing score at 3 months post-treatment.
The mean score in the control group at 3 months is expected to be about 70 points with a standard deviation of 10 based on previous research.
Assuming a 10 unit difference in scores is clinically significant (effect size = 1.0), 17 patients per group will be required to detect a statistically significant difference between groups with 80% power assuming an alpha = 0.05 level of significance.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improved overall family functioning
Time Frame: 12 months
|
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marni Axelrad, Ph.D., Baylor College of Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-31413 (OTHER_GRANT: Baylor College of Medicine)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit and Disruptive Behavior Disorders
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit and Disruptive Behavior DisorderUnited States
-
Erzurum Regional Training & Research HospitalCompletedAttention Deficit and Disruptive Behavior DisordersTurkey
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
New York UniversityCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder | Disruptive BehaviorUnited States
-
Oregon Research InstituteNational Institute on Drug Abuse (NIDA)CompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Child Disruptive Behavior DisordersUnited States
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Hyperactivity Disorder | Mood Disorder | Attention Deficit and Disruptive Behavior Disorder | Mental Disorder Diagnosed in ChildhoodUnited States
-
University of South CarolinaUniversity of Georgia; Oregon Research Institute; The University of QueenslandCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Childhood Disruptive Behavior Disorders | Parent-Child InteractionsUnited States
-
Chiba UniversityCompletedAttention Deficit and Disruptive Behavior Disorders | Hyperkinesis | Attention Deficit Disorder With Hyperactivity DiseaseJapan
-
Tufts Medical CenterNational Institute of Mental Health (NIMH)CompletedAttention Deficit and Disruptive Behavior Disorders | Attention Deficit Disorder With HyperactivityUnited States
-
Centre for Addiction and Mental HealthWomen's College HospitalRecruitingDepression | Attention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Behavior Problem | Emotional Problem | Disruptive Behavior DisorderCanada
Clinical Trials on Immediate Treatment Group
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Holland Bloorview Kids Rehabilitation HospitalActive, not recruitingCerebral Palsy | Chronic PainCanada
-
Drexel UniversityJohns Hopkins University; National Institute on Aging (NIA); University of California...Active, not recruitingDementia | Alzheimer Disease | Frontotemporal Dementia | Vascular Dementia | Dementia With Lewy Bodies | Caregiver Stress Syndrome | Caregiver BurnoutUnited States
-
Association Francaise pour la Recherche ThermaleUniversity Hospital, Grenoble; FloralisWithdrawnObstructive Sleep Apnea Syndrome | Chronic Venous InsufficiencyFrance
-
NHS LothianKarolinska Institutet; University of EdinburghCompleted
-
University of WashingtonNational Institute on Minority Health and Health Disparities (NIMHD); Washington...Completed
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaCompletedStage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral NeuropathyUnited States
-
US Department of Veterans AffairsCompleted
-
University of British ColumbiaBritish Columbia Cancer AgencyRecruiting
-
Association Francaise pour la Recherche ThermaleFloralisRecruitingLymphoma | Breast Cancer | Prostate Cancer | Lymphoedema | Malignant Disease | Gynaecological CancerFrance